Results 261 to 270 of about 589,499 (392)

Paradoxical effect of dopamine-agonists on IGF-1 in patients with prolactinoma: the role of weight. [PDF]

BMC Endocr Disord
Caprio S, Pilli T, Cantara S, Sestini F, Fioravanti C, Ciuoli C, Dalmiglio C, Corbo A, Castagna MG.   +8 more
europepmc   +1 more source

Ameliorating effect of dopamine D2 agonist on impairment of prepulse inhibition in aged rats.

, 1999
Taku Yamaguchi, Shigenori Watanabe, Tsuneyuki Yamamoto   +2 more
openalex   +1 more source

DRD4 gene polymorphism and impulse control disorder induced by dopamine agonists in Parkinson's disease. [PDF]

Ann Clin Transl Neurol
Torres V, Pérez-Montesino J, Fernández-Santiago R, Fernández M, Camara A, Compta Y, Martí MJ, Guerra Beltran À, Rios J, Valldeoriola F, Ezquerra M.   +10 more
europepmc   +1 more source

Comparative Efficacy and Safety of Dopamine Agonists in Advanced Parkinson's Disease With Motor Fluctuations: A Systematic Review and Network Meta-Analysis of Double-Blind Randomized Controlled Trials. [PDF]

Front Neurosci, 2021
Ruan X, Lin F, Wu D, Chen L, Weng H, Yu J, Wang Y, Chen Y, Chen X, Ye Q, Meng F, Cai G.   +11 more
europepmc   +1 more source

Erratum to “estimation of the interstitial free concentration of the putative dopamine D3 receptor selective agonist 7-OH-DPAT in the dorsal striatum of freely moving rats” [Neurosci. Lett. 193 (1995) 65–67]

, 1995
Raul R. Gainetdinov, Tatyana D. Sotnikova, Tatyana V. Grekhova, K.S. Rayevsky   +3 more
openalex   +1 more source

Cortical effects of bromocriptine, a D-2 dopamine receptor agonist, in human subjects, revealed by fMRI [PDF]

, 2001
Daniel Y. Kimberg, Gustavo D. Aguirre, Jessica Lease, Mark D’Esposito   +3 more
openalex   +1 more source

Differential G protein activation by the long and short isoforms of the dopamine D2 receptor

British Journal of Pharmacology, EarlyView.
Background and Purpose The dopamine D2 receptor is expressed as a short (D2S) and a long (D2L) isoform with 29 additional amino acids in the third intracellular loop. The D2S isoform shows higher presynaptic expression than the D2L isoform, and decreased D2S expression has recently been linked to an increased risk for schizophrenia.
David Reiner‐Link, Jakob Sture Madsen, David E. Gloriam, Hans Bräuner‐Osborne, Alexander S. Hauser   +4 more
wiley   +1 more source

Non-Ergot Dopamine Agonists and the Risk of Heart Failure and Other Adverse Cardiovascular Reactions in Parkinson's Disease. [PDF]

Brain Sci
Crispo JAG, Farhat N, Fortin Y, Perez-Lloret S, Sikora L, Morgan RL, Habash M, Gogna P, Kelly SE, Elliott J, Kohen DE, Bjerre LM, Mattison DR, Hessian RC, Willis AW, Krewski D.   +15 more
europepmc   +1 more source

Long‐duration effect and the postsynaptic compartment: Study using a dopamine agonist with a short half‐life [PDF]

, 2001
Fabrizio Stocchi, Laura Vacca, Alfredo Berardelli, Francesca De Pandis, Stefano Ruggieri   +4 more
openalex   +1 more source

ERNEST COST action overview on the (patho)physiology of GPCRs and orphan GPCRs in the nervous system

British Journal of Pharmacology, EarlyView.
G protein‐coupled receptors (GPCRs) are a large family of cell surface receptors that play a critical role in nervous system function by transmitting signals between cells and their environment. They are involved in many, if not all, nervous system processes, and their dysfunction has been linked to various neurological disorders representing important
Necla Birgül Iyison, Clauda Abboud, Dayana Abboud, Abdulrasheed O. Abdulrahman, Ana‐Nicoleta Bondar, Julie Dam, Zafiroula Georgoussi, Jesús Giraldo, Anemari Horvat, Christos Karoussiotis, Alba Paz‐Castro, Miriam Scarpa, Hannes Schihada, Nicole Scholz, Bilge Güvenc Tuna, Nina Vardjan   +15 more
wiley   +1 more source